SCHEMBL20914030

SCHEMBL20914030

COc1cccc2oc(-c3c(C)[nH]c4c(-c5cc(F)cc(F)c5)c(C(F)(F)F)nn4c3=O)nc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PSEN1 P49768 1/20 0.35
▸ PSEN2 P49810 1/20 0.35
▸ APH1B Q8WW43 1/20 0.35
▸ NCSTN Q92542 1/20 0.35
▸ APH1A Q96BI3 1/20 0.35
▸ PSENEN Q9NZ42 1/20 0.35
▸ TNKS O95271 4/20 0.34
▸ TNKS2 Q9H2K2 4/20 0.34
▸ PARP2 Q9UGN5 2/20 0.34
▸ ARF6 P62330 3/20 0.34
▸ F2RL3 Q96RI0 3/20 0.33
▸ UTRN P46939 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ PARP1 P09874 2/20 0.32
▸ PLAT P00750 1/20 0.32
▸ AR P10275 1/20 0.32
▸ APLNR P35414 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20914067 0.94 ARF6 (0.35) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL20837034 0.93 TNKS (0.39) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL20931264 0.92 TNKS (0.39) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL20819069 0.91 TNKS (0.37) TNKSTNKS2PARP2ARF6F2RL3
SCHEMBL20913957 0.90 TNKS (0.34) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL20913911 0.89 HPGD (0.35) TNKSTNKS2PARP2F2RL3MAPT
SCHEMBL20914062 0.89 TNKS (0.39) TNKSTNKS2PARP2ARF6F2RL3
SCHEMBL20914243 0.89 F2RL3 (0.35) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL20914037 0.87 TSHR (0.39) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL20913903 0.87 HTT (0.36) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738056-B2 Pyrazolopyrimidinone compounds and uses thereof ADURO BIOTECH INC. (US) 2020-08-11 — — US disclosed
US-10738056-B2 Pyrazolopyrimidinone compounds and uses thereof ADURO BIOTECH INC. (US) 2020-08-11 — — US disclosed
US-20190119285-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF CHINOOK THERAPEUTICS, INC. 2019-04-25 — — US disclosed
US-20190119285-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF CHINOOK THERAPEUTICS, INC. 2019-04-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738056-B2 Pyrazolopyrimidinone compounds and uses thereof NLRP3, NLRP1, P2RX7 PSEN1 146/4885PSEN2 130/4885APH1B 1222/4885
US-20190119285-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF NLRP3, NLRP1, P2RX7 PSEN1 146/4885PSEN2 130/4885APH1B 1222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback